Anna a very warm welcome to bloomberg daybreak europe, our flagship morning show in the city of london. Im anna edwards. Manus and im manus cranny. So you go away for a weekend ball euphoria donald trump didnt get his health care through the squabbling. The impact on markets is immediate. This is the dollar. The rise of the dollar on the accession of trump into the white house and his promised policies, and there, down, down, down. You seem the dollar touch a fourmonth low. The 200day moving average could be breached. Thisof America Merrill say is still one of the most crowded trades out there even though 32 of their survey say the dollar is overvalued. Buoydata isnt going to the dollar. Manus anna interesting to see just how far the dollar has retreated, almost erasing the gains it has made. Putting up the risk radar takes is a bit further into that dollar story. Weve got dollaryen in there for you. It is 110. 40. Will it go below 110 . Does that trigger some stop orders . We will kee
Novo Nordisk will start selling its hugely popular obesity drug Wegovy in Germany this month, its third European market, but only people who pay from their own pocket or have certain private health insurance plans will be able to get it. A decades-old German law bans public health insurance schemes…
Novo Nordisk will start selling its hugely popular obesity drug Wegovy in Germany this month, its third European market, but only people who pay from their own pocket or have certain private health insurance plans will be able to get it. Novo has yet to set a price for Wegovy in Germany, Europe's largest pharma market.
Novo Nordisk will start selling its hugely popular obesity drug Wegovy in Germany this month, its third European market, but only people who pay from their own pocket or have certain private health insurance plans will be able to get it.
Novo Nordisk
will start selling its hugely popular obesity drug Wegovy in
Germany this month, its third European market, but only people
who pay from their own pocket or have certain private.